| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Shoemaker Shannon | 0001994543 | Sep-18-2023 | officer: Chief Revenue Officer |
| Reynolds Andrew | 0001408209 | Aug-17-2023 | director |
| Davis Robyn C | 0001580601 | Aug-17-2023 | director |
| Hullinger Brian | 0001987597 | Aug-17-2023 | director, officer: President & CEO |
| Weisenhoff Michael | 0001987474 | Jul-21-2023 | other: Assistant Controller |
| Doucot Charles M | 0001739481 | Nov-11-2022 | officer: Executive Vice President |
| Norris William B. | 0001953928 | Nov-08-2022 | other: Assistant Controller |
| NEVIN DARIUS G | 0001184810 | May-06-2022 | other: See Footnote 1 |
| Kamin Peter | 0000937541 | Mar-16-2022 | 10 percent owner |
| Limbek Andrew | 0001843082 | Jan-25-2021 | officer: Vice President & Controller |
| KUBACKI RAYMOND C JR | 0001041889 | Apr-30-2018 | director, officer: Chairman, CEO & President |
| SCHAFFER MICHAEL I | 0001250730 | Apr-30-2018 | officer: VP of Laboratory Operations |
| Lerner Neil | 0001505148 | Apr-30-2018 | officer: VP - Finance |
| Dyke James V. | 0001489027 | May-22-2012 | officer: Vice President - Sales |
| HUIZENGA H WAYNE | 0000917702 | Dec-21-2010 | other: Exit Filing |
| Compton Jonathan D | 0001449454 | Nov-03-2008 | officer: Vice President - Marketing |
| Ruddy Raymond J | 0001447929 | Oct-14-2008 | officer: Vice President/Controller |
| Chmieleski Jennifer | 0001414330 | Oct-02-2007 | officer: Vice President, Controller |
| Harty Thomas M | 0001398738 | May-01-2007 | officer: Principal Accounting Officer |
| TOMENSON WALTER S | 0001250734 | May-24-2005 | director |
| CONNICK HARRY F SR | 0001263356 | May-24-2005 | director |
| CHRISTOPH RICHARD T | 0000947766 | Feb-22-2005 | 10 percent owner |
| DAUSEY WILLIAM | 0001250725 | May-19-2004 | officer: Vice President of Sales |
| MONSON PETER C | 0001250729 | May-19-2004 | officer: VP, Treas., CFO & Asst. Sec. |
| THISTLE WILLIAM R | 0001250732 | May-19-2004 | officer: Sr. VP and Gen. Counsel |
| WEINERT FRED J | 0001041887 | Mar-15-2004 | director |
| ALLEN A CLINTON | 0001041888 | Dec-31-2003 | director, officer: Chairman |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by PSYCHEMEDICS CORP
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001171843-25-001658 (34 Act) Size: KB |
Mar-24-2025 | 25764158 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001171843-25-001575 (33 Act) Size: KB |
Mar-19-2025 | 25753619 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001171843-25-001574 (33 Act) Size: KB |
Mar-19-2025 | 25753199 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001171843-25-001573 (33 Act) Size: KB |
Mar-19-2025 | 25753198 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001171843-25-001572 (33 Act) Size: KB |
Mar-19-2025 | 25753177 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001171843-25-001569 (33 Act) Size: KB |
Mar-19-2025 | 25753144 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001171843-25-001567 (33 Act) Size: KB |
Mar-19-2025 | 25753122 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001171843-25-001565 (33 Act) Size: KB |
Mar-19-2025 | 25753104 |
| 15-12G | Document | Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001171843-25-000010 (34 Act) Size: KB |
Jan-02-2025 | 25502135 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-129515 ( Act) Size: 0 KB |
Dec-17-2024 | |
| 25 | Document | Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange Acc-no: 0001171843-24-006923 (34 Act) Size: 0 KB |
Dec-13-2024 | 241546860 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-128142 ( Act) Size: 0 KB |
Dec-12-2024 | |
| SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001171520-24-000386 (34 Act) Size: KB |
Dec-12-2024 | 241545956 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001420506-24-002619 ( Act) Size: 0 KB |
Dec-12-2024 | |
| SC 13E3/A | Document | Amendment to Schedule filed to report going private transactions Acc-no: 0001171843-24-006864 (34 Act) Size: KB |
Dec-10-2024 | 241539115 |
| 8-K | Document | Current report filing Acc-no: 0001171843-24-006863 (34 Act) Size: KB |
Dec-10-2024 | 241539074 |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001104659-24-127111 ( Act) Size: 0 KB |
Dec-10-2024 | |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-126432 (34 Act) Size: KB |
Dec-06-2024 | 241533636 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001420506-24-002607 ( Act) Size: 0 KB |
Dec-05-2024 | |
| SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001171520-24-000373 (34 Act) Size: KB |
Dec-05-2024 | 241530128 |
Recent 20 filings. View all PSYCHEMEDICS CORP filings
young lad who new his job ansered questions and new what was best for me.
Very good communication and delivery made within the timeframe I was advised of
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by